These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. MicroRNA-379 acts as a tumor suppressor in non-small cell lung cancer by targeting the IGF‑1R-mediated AKT and ERK pathways. Zhou F, Nie L, Feng D, Guo S, Luo R. Oncol Rep; 2017 Sep; 38(3):1857-1866. PubMed ID: 28731178 [Abstract] [Full Text] [Related]
4. microRNA-935 is reduced in non-small cell lung cancer tissue, is linked to poor outcome, and acts on signal transduction mediator E2F7 and the AKT pathway. Wang C, Li S, Xu J, Niu W, Li S. Br J Biomed Sci; 2019 Jan; 76(1):17-23. PubMed ID: 30203720 [Abstract] [Full Text] [Related]
11. MicroRNA-124 Functions as a Tumor Suppressor by Regulating CDH2 and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer. Ma T, Zhao Y, Wei K, Yao G, Pan C, Liu B, Xia Y, He Z, Qi X, Li Z, Wang J, Shao Y. Cell Physiol Biochem; 2016 Jan; 38(4):1563-74. PubMed ID: 27073840 [Abstract] [Full Text] [Related]
12. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion. Li Q, Ran P, Zhang X, Guo X, Yuan Y, Dong T, Zhu B, Zheng S, Xiao C. Cell Physiol Biochem; 2018 Jan; 50(3):987-1004. PubMed ID: 30355927 [Abstract] [Full Text] [Related]
15. MicroRNA-183 Acts as a Tumor Suppressor in Human Non-Small Cell Lung Cancer by Down-Regulating MTA1. Yang CL, Zheng XL, Ye K, Ge H, Sun YN, Lu YF, Fan QX. Cell Physiol Biochem; 2018 Jan; 46(1):93-106. PubMed ID: 29587281 [Abstract] [Full Text] [Related]
16. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C, Shan Z, Hong J, Yang L. Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [Abstract] [Full Text] [Related]
17. Long non‑coding RNA MEG3 inhibits cell migration and invasion of non‑small cell lung cancer cells by regulating the miR‑21‑5p/PTEN axis. Lv D, Bi Q, Li Y, Deng J, Wu N, Hao S, Zhao M. Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495842 [Abstract] [Full Text] [Related]
18. MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene. Li Y, Zhang H, Li Y, Zhao C, Fan Y, Liu J, Li X, Liu H, Chen J. Mol Carcinog; 2018 Jan; 57(1):125-136. PubMed ID: 28940757 [Abstract] [Full Text] [Related]
19. miR‑593 inhibits proliferation and invasion and promotes apoptosis in non‑small cell lung cancer cells by targeting SLUG‑associated signaling pathways. Wei F, Wang M, Li Z, Wang Y, Zhou Y. Mol Med Rep; 2019 Dec; 20(6):5172-5182. PubMed ID: 31661137 [Abstract] [Full Text] [Related]
20. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling. Zhao Y, Ye X, Chen R, Gao Q, Zhao D, Ling C, Qian Y, Xu C, Tao M, Xie Y. Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247 [Abstract] [Full Text] [Related] Page: [Next] [New Search]